Immuneering Corp. (IMRX)
3.745
-0.28
(-6.84%)
USD |
NASDAQ |
Oct 30, 16:00
3.74
0.00 (0.00%)
After-Hours: 20:00
Immuneering Price : 3.745 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.01 | 4.07 | 3.72 | 3.745 | 1.139M |
| Oct 29, 2026 | 3.99 | 4.10 | 3.87 | 4.02 | 777033.0 |
| Oct 28, 2026 | 3.80 | 4.155 | 3.79 | 3.99 | 1.443M |
| Oct 27, 2026 | 3.72 | 3.888 | 3.70 | 3.83 | 700080.0 |
| Oct 26, 2026 | 3.73 | 3.78 | 3.65 | 3.71 | 579803.0 |
| Oct 23, 2026 | 3.78 | 3.78 | 3.585 | 3.73 | 726539.0 |
| Oct 22, 2026 | 3.72 | 3.835 | 3.70 | 3.81 | 527135.0 |
| Oct 21, 2026 | 3.73 | 3.80 | 3.680 | 3.74 | 481882.0 |
| Oct 20, 2026 | 3.70 | 3.841 | 3.67 | 3.73 | 926845.0 |
| Oct 19, 2026 | 3.61 | 3.67 | 3.560 | 3.66 | 427112.0 |
| Oct 16, 2026 | 3.65 | 3.68 | 3.575 | 3.59 | 747890.0 |
| Oct 15, 2026 | 3.42 | 3.71 | 3.38 | 3.64 | 934285.0 |
| Oct 14, 2026 | 3.51 | 3.598 | 3.41 | 3.42 | 805722.0 |
| Oct 13, 2026 | 3.86 | 3.86 | 3.545 | 3.56 | 734913.0 |
| Oct 12, 2026 | 3.94 | 3.945 | 3.814 | 3.86 | 529791.0 |
| Oct 09, 2026 | 3.75 | 3.955 | 3.68 | 3.94 | 709719.0 |
| Oct 08, 2026 | 3.83 | 3.83 | 3.60 | 3.74 | 1.923M |
| Oct 07, 2026 | 3.78 | 3.915 | 3.74 | 3.86 | 747682.0 |
| Oct 06, 2026 | 4.06 | 4.09 | 3.81 | 3.83 | 898442.0 |
| Oct 05, 2026 | 4.07 | 4.12 | 4.02 | 4.04 | 482714.0 |
| Oct 02, 2026 | 4.10 | 4.145 | 4.02 | 4.07 | 588944.0 |
| Oct 01, 2026 | 4.10 | 4.17 | 4.01 | 4.03 | 538180.0 |
| Sep 30, 2026 | 4.16 | 4.23 | 4.09 | 4.095 | 596821.0 |
| Sep 29, 2026 | 4.16 | 4.16 | 4.065 | 4.13 | 574595.0 |
| Sep 28, 2026 | 4.25 | 4.25 | 4.125 | 4.16 | 598654.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.59 |
| Alnylam Pharmaceuticals, Inc. | 165.00 |
| Anika Therapeutics, Inc. | 20.95 |
| Savara, Inc. | 4.82 |
| Vericel Corp. | 40.26 |
Price Related Metrics
| Price to Book Value | 1.438 |
| Earnings Yield | -27.46% |
| Market Cap | 242.29M |